» Articles » PMID: 31415041

Ceftriaxone Reduced Susceptible Neisseria Gonorrhoeae in the Netherlands, 2009 to 2017: From PenA Mosaicism to A501T/V Nonmosaicism

Overview
Journal Sex Transm Dis
Date 2019 Aug 16
PMID 31415041
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To compare molecular and epidemiological differences between ceftriaxone-reduced susceptible (CRO-RS) and ceftriaxone-susceptible (CRO-S) N. gonorrhoeae (Ng) and to study the genetic relatedness of CRO-RS isolates.

Methods: Demographic and clinical data and samples for cultures were routinely collected from gonorrhoea patients visiting the Amsterdam STI clinic in 2009 to 2017. Ng multiantigen sequence typing (NG-MAST) and penA types were compared between CRO-RS and CRO-S Ng (frequency matched on year of isolation and sexual risk group). Minimum spanning trees were produced based on multilocus variable number of tandem repeats analysis for Ng (NG-MLVA) genotypes.

Results: We selected 174 CRO-RS isolates (minimum inhibitory concentration, ≥0.064 mg/L) and 174 CRO-S isolates (minimum inhibitory concentration, ≤0.016 mg/L). Demographic and clinical characteristics of patients were overall comparable between those infected with CRO-RS Ng and CRO-S Ng. However, CRO-RS isolates were more often collected from the pharyngeal site (odds ratios [OR], 3.64; P < 0.001), and patients with CRO-RS Ng were less often human immunodeficiency virus (HIV) and syphilis positive (OR, 0.63; P = 0.041 and OR, 0.58; P = 0.028, respectively). We identified 12 clusters based on NG-MLVA genotypes, including 3 large (>25 isolates) clusters predominantly containing CRO-RS isolates. Those from cluster 1 (n = 32) were mostly from 2009 to 2012 (n = 24; 75.0%), with a mosaic penA XXXIV pattern (n = 27; 84.4%) and belonging to NG-MAST genogroup G1407 (n = 24; 75.0%). Isolates from cluster 2 (n = 29) were mostly from 2013 to 2015 (n = 24; 82.7%), had a nonmosaic penA IX + A501T mutation (n = 22; 75.9%) and NG-MAST G2400 (n = 14; 48.3%). Most isolates from cluster 3 (n = 37) were from 2015 to 2017 (n = 26; 70.2%), had a nonmosaic penA IV + A501V mutation (n = 24; 64.9%) and NG-MAST G2318 (n = 22; 59.5%).

Conclusions: We observed a shift in the predominant penA (from mosaic toward nonmosaic plus A501T/V mutation), NG-MAST and NG-MLVA types among CRO-RS Ng over time. This indicates a successive spread of different CRO-RS Ng clones.

Citing Articles

Genomic epidemiology of in Shenzhen, China, during 2019-2020: increased spread of ceftriaxone-resistant isolates brings insights for strengthening public health responses.

Wang D, Li Y, Zhang C, Zeng Y, Peng J, Wang F Microbiol Spectr. 2023; :e0172823.

PMID: 37732794 PMC: 10580820. DOI: 10.1128/spectrum.01728-23.


Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019.

Visser M, Gotz H, van Dam A, van Benthem B Euro Surveill. 2022; 27(34).

PMID: 36017715 PMC: 9413857. DOI: 10.2807/1560-7917.ES.2022.27.34.2200081.


Reliability of Genetic Alterations in Predicting Ceftriaxone Resistance in Neisseria gonorrhoeae Globally.

Yu Lin E, Adamson P, Ha S, Klausner J Microbiol Spectr. 2022; 10(2):e0206521.

PMID: 35348352 PMC: 9045316. DOI: 10.1128/spectrum.02065-21.


Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.

de Korne-Elenbaas J, Bruisten S, de Vries H, van Dam A J Antimicrob Chemother. 2021; 76(7):1759-1768.

PMID: 33739419 PMC: 8212776. DOI: 10.1093/jac/dkab082.


Evaluating the generalizability of a multiplex real-time PCR assay for predicting decreased susceptibility to ceftriaxone in a global set of Neisseria gonorrhoeae sequences.

Lin E, Adamson P, Klausner J J Antimicrob Chemother. 2020; 76(4):1104-1106.

PMID: 33351912 PMC: 7953313. DOI: 10.1093/jac/dkaa525.